Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05489159 · ClinicalTrials.gov registry record
Sleep and IR in Transgender Adolescents
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 10
- Enrollment target
NCT05489159: Completed study, sponsored by Duke University.
NCT05489159 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05489159 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
Disordered sleep is a health issue with significant impacts on physical and psychological well-being that has increased in prevalence, but its impact on transgender adolescents has not been fully quantified. While there is found to be an impact of sex steroids on sleep, and sex-dependent differences in the impact of sleep duration and quality on insulin resistance (IR), there is limited available information regarding the impact of Gender Affirming Hormone Therapy (GAHT) for transgender individuals on sleep and IR. Our study aims to quantify the impacts of GAHT on sleep and IR in the pediatric transgender population as well as determine the degree of correlation of sleep to IR in this population.
Primary Outcome
An actigraphy device will track sleep and assay facets of sleep quality
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2022-10-12 |
| Est. Completion | 2024-08-16 |
What the finished NCT05489159 record still lists
NCT05489159 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT05489159 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05489159 about?
NCT05489159 is a clinical study titled "Sleep and IR in Transgender Adolescents". Disordered sleep is a health issue with significant impacts on physical and psychological well-being that has increased in prevalence, but its impact on transgender adolescents has not been fully quantified. While there is found to be an impact of sex steroids on sleep, and sex-dependent differences...
What is the current status of trial NCT05489159?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2022-10-12. Estimated completion is 2024-08-16.
Who is sponsoring clinical trial NCT05489159?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI